# A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies

Source: https://onco.cc/trials/nct05589896/  
OnCo record `nct05589896` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of an investigational treatment in acute lymphoblastic leukaemia, acute myeloid leukaemia, chronic lymphocytic leukaemia, chronic myeloid leukaemia, myelodysplastic syndromes / neoplasms and hodgkin lymphoma, run by Ossium Health, Inc., active and no longer recruiting.

## Summary

A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies is a phase 1/2 interventional study registered as NCT05589896 by Ossium Health, Inc., with 12 participants enrolled, started 2024-08-16 and due to reach its primary completion in 2026-07-14.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT05589896
- Phase: 1/2
- Setting: A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
- Sponsor: Ossium Health, Inc.
- Enrolled: 12

## Sources

- ClinicalTrials.gov NCT05589896: https://clinicaltrials.gov/study/NCT05589896

## Connected records

- cancers: [Acute lymphoblastic leukaemia](https://onco.cc/cancers/all-leukemia/), [Acute myeloid leukaemia](https://onco.cc/cancers/aml/), [Chronic lymphocytic leukaemia](https://onco.cc/cancers/cll/), [Chronic myeloid leukaemia (CML)](https://onco.cc/cancers/cml/), [Hodgkin lymphoma](https://onco.cc/cancers/hodgkin-lymphoma/), [Myelodysplastic syndromes / neoplasms (MDS)](https://onco.cc/cancers/mds/)

---
JSON: https://onco.cc/api/v1/entities/nct05589896.json